Projected Return Density against MarketGiven investment horizon of 30 days, the stock has beta coefficient of 12.81 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are expected to be negative, Biostar will likely underperform. In addition to that, Biostar Pharmaceuticals Inc has alpha of 2.6046 implying that it can potentially generate 2.6046% excess return over S&P 500 after adjusting for the inherited market risk (beta). Given investment horizon of 30 days, the coefficient of variation of Biostar is 501.93. The daily returns are destributed with a variance of 317.14 and standard deviation of 17.81. The mean deviation of Biostar Pharmaceuticals Inc is currently at 11.64. For similar time horizon, the selected benchmark (S&P 500) has volatility of 0.45
Actual Return VolatilityBiostar Pharmaceuticals Inc inherits 17.81% risk (volatility on return distribution) over the 30 days horizon. S&P 500 shows 0.45% volatility of returns over 30 trading days.
Follow Biostar Volatility with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Biostar Pharmaceuticals Inc has a volatility of 17.81 and is 39.58 times more volatile than S&P 500. 96% of all equities and portfolios are less risky than Biostar. Compared with the overall equity markets, volatility of historical daily returns of Biostar Pharmaceuticals Inc is higher than 96 (%) of all global equities and portfolios over the last 30 days. Use Biostar Pharmaceuticals Inc to protect against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of Biostar to be traded at $2.03 in 30 days. As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Biostar will likely underperform.
Biostar correlation with market
Biostar Current Risk Indicators
Suggested Divercification Pairs